Иммуносупрессивная терапия и трансплантация гемопоэтических стволовых клеток в лечении детей с приобретенной апластической анемией
Диссертация
Впервые в России на репрезентативной группе детей и подростков, больных ПАА проведен подробный анализ эффективности и отдаленных результатов различных видов терапии. Показано, что показатель долгосрочной бессобытийной выживаемости (EFS) при применении аллогенной ТГСК составляет 65%, это достоверно выше в сравнении с результатами комбинированной ИСТ (АТГ+ CsA) — 37% и монотерапиии CsA — 27… Читать ещё >
Список литературы
- Абдулкадыров K.M., Ганапиев A.A., Шилова Е.Р и соавт. Результаты лечения больных апластической анемией различными дозами антилимфоцитарного глобулина. Тер. Архив, 1995, 67(8), 51−54.
- Богачева Н.Ю., Шнейдер М. М., Масчан A.A. «Циклоспориновая зависимость» при лечении тяжелой апластической анемии у детей. Гематол. и Трансфузиол., 1996- 41(2): 18−21.
- Масчан A.A. Лечение апластических анемий у детей. Автореферат диссертации на соискание ученой степени доктора медицинских наук 1998.
- Масчан A.A.: Врожденные и приобретенные апластические анемии. In Под редакцией А. Г. Румянцева и Е. В. Самочатовой (ed): «Практическое руководство по детским болезням. Том IV. Гематология/онкология детского возраста.» 2004
- Масчан A.A., Богачева Н. Ю., Крыжановский О. И. и соавт. Эффективность циклоспорина, А в лечении гипопластических анемий у детей. Педиатрия. 1995- 2: 3740.
- Самочатова Е.В., Богачева Н. Ю., Литвинов Д.В: «Диагностика и лечение приобретенной апластической анемии у детей с использованием комбинированной иммуносупрессии. Методические рекомендации. Москва, РГМУ.» 1999.
- Михайлова Е.А., Ядрихинская В. Н., Савченко В. Г. Апластическая анемия и вирусный гепатит (Постгепатитная апластическая анемия). Тер.Архив. 1999- 71(7): 6469.
- Никитин Д.О., Алексеев H.A. Лечение приобретенной апластической анемии у детей антилимфоцитарным глобулином Советского производства. Гематол. и Трансфузиол. 1990- 35(1): 23−25.
- Савченко В.Г., Михайлова Е. А., Любимова Л. С. и соавт. Сравнительная эффективность спленэктомии и терапии антилимфоцитарным глобулином пациентов с апластической анемией. Тер.Архив. 1990- 62(7): 76−81.
- Федоровская H.A., Поздеев Н. М., Югов Ю. И., Истомина Л. А. Роль спленэктомии в лечении тяжелой апластической анемии. Гематол. и Трансфузиол. 1995- 40(6): 19−21.
- Федоровская H.A., Истомина Л. А., Копанева Т. Г. и соавт. Использование циклофосфана в иммунодепрессивной терапии тяжелой апластической анемии. Тер.Архив. 1997- 69(4): 61−64.
- Abdulkadyrov KM, Bessmel’tsev SS, Balashova VA, et al. r Morphological and pathogenetic aspects of aplastic anemia. Morfologiia 1995- 108:58−62.
- Abdulsalam M, Markum AH, Dijat IW, et al.: Prognostic value of fetal hemoglobin level in aplastic anemia. Paediatr Indones 1972- 12:350−354.
- Ades L, Mary JY, Robin M, et al.: Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004- 103:2490−2497.
- Adil SN, Burney IA, Kakepoto GN, Khurshid M: Epidemiological features of aplastic anaemia in Pakistan. J Pak Med Assoc 2001- 51:443−445.
- Agarwal BR, Gulvady A, Bhalla K, et al.: Treatment of aplastic anemia in children with high dose methyl prednisolone. Indian Pediatr 1995- 32:1061−1065.
- Ajlouni K, Doeblin TD: The syndrome of hepatitis and aplastic anaemia. Br J Haematol 1974- 27:345−355.
- Amare M, Abdou NL, Robinson MG, Abdou N1: Aplastic anemia associated with bone marrow suppressor T-cell hyperactivity: successful treatment with antithymocyte globulin. Am J Hematol 1978- 5:25−32.
- Appelbaum FR, Cheever MA, Fefer A, et al.: Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: evidence for two mechanisms of graft failure. Blood 1985- 65:553−556.
- Appelbaum FR, Fefer A: The pathogenesis of aplastic anemia. Semin Hematol 1981- 18:241−257.
- Appelbaum FR, Fefer A, Cheever MA, et al.: Treatment of aplastic anemia by bone marrow transplantation in identical twins. Blood 1980- 55:1033−1039.
- Bacigalupo A GEeal: Graft rejection and second bone marrow transplants for acquired aplastic anemia: a report from the aplastic anemia working party of the European Bone Marrow transplant Group. Bone Marrow Transplant 1994- 13:233−237.
- Bacigalupo A: Aplastic anemia: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program 2007- 2007:23−28.
- Bacigalupo A, Chaple M, Hows J, et al.: Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol 1993- 83:145−151.
- Bacigalupo A, Giordano D, van Lint MT, et al.: Bolus methylprednisolone in severe aplastic anemia. N Engl J Med 1979- 300:501−502.
- Bacigalupo A, Passweg J: Diagnosis and treatment of acquired aplastic anemia. Hematol Oncol Clin North Am 2009- 23:159−170.
- Bacigalupo A, Piaggio G, Podesta M, et al.: In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia. Stem Cells 1993- 11 Suppl 2:175−179.
- Barrett AJ: Bone marrow transplantation in aplastic anaemia. Br Med J 1974- 3:40−41.
- Barrett AJ, Faille A, Saal F, et al.: Marrow graft rejection and inhibition of growth in culture by serum in aplastic anaemia. J Clin Pathol 1978- 31:1244−1248.
- Benesch M, Urban C, Sykora KW, et al.: Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia. Br J Haematol 2004- 125:58−63.
- Bhattacharyya M, Oakervee H, Dalley C, et al.: Hepatitis-associated aplastic anaemia treated successfully with antilymphocyte globulin. Clin Lab Haematol 2005- 27:331−333.
- Bielory L, Gascon P, Lawley TJ, et al.: Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine (Baltimore) 1988- 67:40−57.
- Bithell TC, Wintrobe MM: Drug-induced aplastic anemia. Semin Hematol 1967- 4:194 221.
- Bodebender RH: Hepatitis and aplastic anemia. Am J Dis Child 1971- 122:440−441.
- Bonnefoy-Berard N, Verrier B, Vincent C, Revillard JP: Inhibition of CD25 (IL-2R alpha) expression and T-cell proliferation by polyclonal anti-thymocyte globulins. Immunology 1992- 77:61−67.
- Bonnefoy-Berard N, Vincent C, Revillard JP: Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991- 51:669−673.
- Bonnefoy-Berard N, Vincent C, Verrier B, Revillard JP: Monocyte-independent T-cell activation by polyclonal antithymocyte globulins. Cell Immunol 1992- 143:272−283.
- Bortin MM, Saltzstein EC, Waisbren BA, et al.: Bone marrow transplantation for aplastic anemia. Establishment of chimerism using multiple HL-A identical donors following pretreatment with cyclophosphamide. Transplantation 1971- 11:573−575.
- Bourdage JS, Hamlin DM: Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995- 59:1194−1200.
- Brodsky RA: High-dose cyclophosphamide for aplastic anemia and autoimmunity. Curr Opin Oncol 2002- 14:143−146.
- Brodsky RA: Paroxysmal nocturnal hemoglobinuria: stem cells and clonality. Hematology Am Soc Hematol Educ Program 2008- 2008:111−115.
- Brodsky RA, Chen AR, Brodsky I, Jones RJ: High-dose cyclophosphamide as salvage therapy for severe aplastic anemia. Exp Hematol 2004- 32:435−440.
- Brodsky RA, Jones RJ: High-dose cyclophosphamide in aplastic anaemia. Lancet 2001- 357:1128−1129.
- Brodsky RA, Sensenbrenner LL, Jones RJ: Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood 1996- 87:491−494.
- Brodsky RA, Sensenbrenner LL, Smith BD, et al.: Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia. Ann Intern Med 2001- 135:477−483.
- Brown KE, Tisdale J, Barrett AJ, et al.: Hepatitis-associated aplastic anemia. N Engl J Med 1997- 336:1059−1064.
- Bunin N, Aplenc R, Iannone R, et al.: Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion. Bone Marrow Transplant 2005- 35:369−373.
- Burkhardt R, Kettner G, Bohm W, et al.: Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study. Bone 1987- 8:157−164.
- Camitta B, O’Reilly RJ, Sensenbrenner L, et al.: Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood 1983- 62:883−888.
- Camitta BM: The role of viral infections in aplastic anemia. Haematol Blood Transfus 1979- 24:39−46.
- Camitta BM: Pathogenesis and treatment of aplastic anemia. Rinsho Ketsueki 1984- 25:459−469.
- Camitta BM, Doney K: Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. Am J Pediatr Hematol Oncol 1990- 12:411−424.
- Camitta BM, Nathan DG, Forman EN, et al.: Posthepatitic severe aplastic anemia~an indication for early bone marrow transplantation. Blood 1974- 43:473−483.
- Camitta BM, Storb R, Thomas ED: Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 1982- 306:645−652.
- Camitta BM, Storb R, Thomas ED: Aplastic anemia (second of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 1982- 306:712−718.
- Camitta BM, Thomas ED, Nathan DG, et al.: Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976- 48:63−70.
- Champlin R, Ho W, Gale RP: Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 1983- 308:113−118.
- Champlin RE, Feig SA, Sparkes RS, Galen RP: Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease. Br J Haematol 1984- 56:455−463.
- Champlin RE, Perez WS, Passweg JR, et al.: Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens. Blood 2007- 109:4582−4585.
- CONE TE, ABELSON SM: Aplastic anemia following two days of chloramphenicol therapy- case report of a fatality in a 6-year old girl. J Pediatr 1952- 41:340−342.
- Conrad ME: Fatal aplastic anemia associated with allopurinol therapy. Am J Hematol 1986−22:107−108.
- Dan K, Tajika K, Yamada T, et al.: Therapeutic results of high-dose bolus methylprednisolone and prediction of response by in vitro tests in aplastic anemia. Rinsho Ketsueki 1987- 28:22−27.
- Davies JK, Guinan EC: An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol 2007- 136:549−564.
- De Planque MM, van Krieken JH, Kluin-Nelemans HC, et al.: Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow-up. Br J Haematol 1989- 72:439−444.
- Deeg HJ, O’Donnell M, Tolar J, et al.: Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006- 108:1485−1491.
- Desposito E. AJTLGaSNJ: Bone marrow failure in pediatric patients. J Pediatr 1964- 64:683.
- Dilloo D, Vohringer R, Josting A, et al.: Bone marrow fibroblasts from children with aplastic anemia exhibit reduced interleukin-6 production in response to cytokines and viral challenge. Pediatr Res 1995- 38:716−721.
- Doll R, Lunde PK, Moeschlin S: Analgesics, agranulocytosis, and aplastic anaemia. Lancet 1987- 1:101.
- Doney K, Storb R, Buckner CD, et al.: Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol 1987- 15:239−242.
- Doney K, Storb R, Buckner CD, et al.: Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol 1987- 15:239−242.
- Dubey S, Shukla P, Nityanand S: Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia. Ann Hematol 2005- 84:572−577.
- Dufour C, Corcione A, Svahn J, et al.: Interferon gamma and tumour necrosis factor alpha are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia. Br J Haematol 2001- 115:1023−1031.
- Duhamel G, Muratore R, Bryon P, Horschowski N: Histological prognosis in aplastic anaemia. Bibl Haematol 1978- 45:87−95.
- Dulley FL, Vigorito AC, Aranha FJ, et al.: Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection. Bone Marrow Transplant 2004- 33:9−13.
- Dyer NH, Hughes DT, Jenkins GC: Aplastic anaemia after carbamazepine. Br Med J 1966- 1:108.
- Ehrlich P.: Ueber einem Fall von Anamie mit Bemerkungen uber regenerative Veranderungen des Knochenmarks. Charite-Annalen 1888- 13:300−309.
- Faille A, Barrett AJ, Balitrand N, et al.: Effect of antilymphocyte globulin on granulocyte precursors in aplastic anaemia. Br J Haematol 1979- 42:371−380.
- Fefer A, Thomas ED, Buckner CD, et al.: Marrow transplants in aplastic anemia and leukemia. Semin Hematol 1974- 11:353−367.
- Fitchen JJ, Cline MJ, Saxon A, Golde DW: Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis. Am J Med 1979- 66:537−542.
- Fohlmeister I, Fischer R, Modder B, et al.: Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 1985- 38:1218−1224.
- Foon KA, Mitsuyasu RT, Schroff RW, et al.: Immunologic defects in young male patients with hepatitis-associated aplastic anemia. Ann Intern Med 1984- 100:657−662.
- Frickhofen N. LJMaYNS: Etiologic mechanisms of hematopoietic failure. Am J Pediatr Hematol Oncol 1990- 12:385−395.
- Frickhofen N, Heimpel H, Kaltwasser JP, Schrezenmeier H: Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood 2003- 101:1236−1242.
- Frickhofen N, Heit W, Raghavachar A, et al.: Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin. Klin Wochenschr 1986- 64:1165−1170.
- Frickhofen N, Kaltwasser JP: Immunosuppressive treatment of aplastic anemia: a prospective, randomized multicenter trial evaluating antilymphocyte globulin (ALG) versus ALG and cyclosporin A. Blut 1988- 56:191−192.
- Frickhofen N, Kaltwasser JP, Schrezenmeier H, et al.: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991- 324:1297−1304.
- Frickhofen N, Rosenfeld SJ: Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol 2000- 37:56−68.
- Gafiter-Gvili A, Ram R, Gurion R, et al.: ATG plus cyclosporine reduces all-cause mortality in patients with severe aplastic anemia—systematic review and meta-analysis. Acta Haematol 2008- 120:237−243.
- Gascon P, Zoumbos NC, Scala G, et al.: Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulin. Blood 1985- 65:407 413.
- Gertz MA, Garton JP, Jennings WH: Aplastic anemia due to tocainide. N Engl J Med 1986−314:583−584.
- Gibson FM, Scopes J, Daly S, et al.: Haemopoietic growth factor production by normal and aplastic anaemia stroma in long-term bone marrow culture. Br J Haematol 1995- 91:551−561.
- Gluckman E DAPADP: Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). Br J Haematol 1982.
- Gluckman E, Devergie A, Faille A, et al.: Treatment of severe aplastic anemia with antilymphocyte globulin and androgens. Exp Hematol 1978- 6:679−687.
- Gluckman E, Devergie A, Faille A, et al.: Antilymphocyte globulin treatment in severe aplastic anemia—comparison with bone marrow transplantation. Report of 60 cases. Haematol Blood Transfus 1979- 24:171−179.
- Gluckman E, Devergie A, Gerotta I, et al.: Bone marrow transplantation in 65 patients with severe aplastic anemia. Bull Cancer 1981- 68:74−77.
- Gluckman E, Devergie A, Poros A, Degoulet P: Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). Br J Haematol 1982- 51:541−550.
- Gluckman E, Devergie A, Poros A, Degoulet P: Results of immunosuppression in 170 cases of severe aplastic anaemia. Report of the European Group of Bone Marrow Transplant (EGBMT). Br J Haematol 1982- 51:541−550.
- Gluckman E, Esperou H, Devergie A, et al.: Pediatric bone marrow transplantation for leukemia and aplastic anemia. Report of 222 cases transplanted in a single center. Nouv Rev Fr Hematol 1989−31:111−114.
- Gluckman E, Esperou-Bourdeau H: Recent treatments of aplastic anemia. The International Group on SAA. Nouv Rev Fr Hematol 1991- 33:507−510.
- Gluckman E, Horowitz MM, Champlin RE, et al.: Bone marrow transplantation for severe aplastic anemia: influence of conditioning and grafi-versus-host disease prophylaxis regimens on outcome. Blood 1992- 79:269−275.
- Gordon MY: Circulating inhibitors of granulopoiesis in patients with aplastic anaemia. Br J Haematol 1978- 39:491−496.
- Gordon MY: Serum inhibitors in aplastic anaemia. Haematol Blood Transfus 1979- 24:247−254.
- Gordon-Smith EC: Clinical features of aplastic anaemia. Haematol Blood Transfus 1979- 24:9−13.
- Gordon-Smith EC, Issaragrisil S: Epidemiology of aplastic anaemia. Baillieres Clin Haematol 1992- 5:475−491.
- Grosdow DM, Sliskow SS: Results of splenectomy in patients with hypoplastic and aplastic anemia. Folia Haematol Int Mag Klin Morphol Blutforsch 1975- 102:639−648.
- Guinan EC: Acquired aplastic anemia in childhood. Hematol Oncol Clin North Am 2009- 23:171−191.
- Gupta A, Bansal D, Marwaha RK, Trehan A: Hepatitis-associated aplastic anemia: successful outcome following immunosuppressive therapy. Indian J Gastroenterol 2005- 24:175−176.
- HARGRAVES MM, MILLS SD, HECK FJ: Aplastic anemia associated with administration of chloramphenicol. J Am Med Assoc 1952- 119:1293−1300.
- Heimpel H: Aplastic anemia before bone marrow transplantation and antilymphocyte globulin. Acta Haematol 2000- 103:11−15.
- Herrmann F, Griffin JD, Meuer SG, Meyer zum Buschenfelde KH: Establishment of an interleukin 2-dependent T cell line derived from a patient with severe aplastic anemia, which inhibits in vitro hematopoiesis. J Immunol 1986- 136:1629−1634.
- Hilton RC: Aplastic anaemia and infectious hepatitis. Lancet 1970- 2:826.
- Hinterberger W, Adolf G, Aichinger G, et al.: Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 1988- 72:266−272.
- Hinterberger W, Rowlings PA, Hinterberger-Fischer M, et al.: Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med 1997- 126:116−122.
- HOLLIS WJ, HANISCH LE: Aplastic anemia- report of case following Chloromycetin therapy and infectious hepatitis. J La State Med Soc 1953- 105:385−389.
- Holmberg LA, Seidel K, Leisenring W, Torok-Storb B: Aplastic anemia: analysis of stromal cell function in long-term marrow cultures. Blood 1994- 84:3685−3690.
- Hows J, Harris R, Palmer S, Gordon-Smith EC: Immunosuppression with cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia: preliminary studies. Br J Haematol 1981- 48:227−236.
- Hows JM, Palmer S, Gordon-Smith EC: Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia. Transplantation 1982- 33:382−386.
- Idel’son LI, Pogorel’skaia EP, Il’in GP, Gorodetskii VM: Effectiveness of the treatment of severe aplastic anemia (splenectomy and immunosuppression). Ter Arkh 1984- 56:9398.
- Inamoto Y, Suzuki R, Kuwatsuka Y, et al.: Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Biol Blood Marrow Transplant 2008- 14:43−49.
- Isitano AM MJGSeal: In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 2004- 364:355−364.
- Issaragrisil S: Epidemiology of aplastic anemia in Thailand. Thai Aplastic Anemia Study Group. Int J Hematol 1999- 70:137−140.
- Issaragrisil S, Chansung K, Kaufman DW, et al.: Aplastic anemia in rural Thailand: its association with grain farming and agricultural pesticide exposure. Aplastic Anemia Study Group. Am J Public Health 1997- 87:1551−1554.
- Issaragrisil S, Kaufman DW, Anderson T, et al.: The epidemiology of aplastic anemia in Thailand. Blood 2006- 107:1299−1307.
- Issaragrisil S, Kaufman DW, Anderson T, et al.: Low drug attributability of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Blood 1997- 89:4034−4039.
- Issaragrisil S, Leaverton PE, Chansung K, et al.: Regional patterns in the incidence of aplastic anemia in Thailand. The Aplastic Anemia Study Group. Am J Hematol 1999- 61:164−168.
- Ito T, Hiraiwa M, Ishikawa Y, et al.: Lymphocytapheresis in a patient with severe aplastic anemia. Acta Haematol 1988- 80:167−170.
- Itterbeek P, Vandenberghe P, Nevens F, et al.: Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature. Transpl Int 2002- 15:117−123.
- Jeannet M, Rubinstein A, Pelet B, Kummer H: Prolonged remission of severe aplastic anemia after ALG pretreatment and HL-A-semi-incompatible bone-marrow cell transfusion. Transplant Proc 1974- 6:359−363.
- Jeannet M, Speck B, Rubinstein A, et al.: Autologous marrow reconstitutions in severe aplastic anaemia after ALG pretreatment and HL-A semi-incompatible bone marrow cell transfusion. Acta Haematol 1976- 55:129−139.
- Jeng MR, Naidu PE, Rieman MD, et al.: Granulocyte-macrophage colony stimulating factor and immunosuppression in the treatment of pediatric acquired severe aplastic anemia. Pediatr Blood Cancer 2005- 45:170−175.
- Kagan WA, Ascensao JL, Fialk MA, et al.: Studies on the pathogenesis of aplastic anemia. Am J Med 1979- 66:444−449.
- Kahl C, Leisenring W, Deeg HJ, et al.: Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 2005- 130:747−751.
- Kang HJ, Shin HY, Choi HS, Ahn HS: Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia. Bone Marrow Transplant 2004- 34:939−943.
- Kaufman D.W. KJPSS: Risk of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drug: The International Agranulocytosis and Aplastic Anemia Study. Clin Pharmacol Ther 1991- 49:330−341.
- Kaufman DW, Kelly JP, Issaragrisil S, et al.: Relative incidence of agranulocytosis and aplastic anemia. Am J Hematol 2006- 81:65−67.
- Keisu M, Ost A, Sandberg M, Wiholm BE: An international case-control study. Aplastic anemia is an unusual disease previously overdiagnosed. Lakartidningen 1990- 87:25 012 503.
- KILLANDER A, Lundmark KM, Sjolin S: Idiopathic aplastic anaemia in children. Results of androgen treatment. Acta Paediatr Scand 1969- 58:10−14.
- Killick SB, Cox CV, Marsh JC, et al.: Mechanisms of bone marrow progenitor cell apoptosis in aplastic anaemia and the effect of anti-thymocyte globulin: examination of the role of the Fas-Fas-L interaction. Br J Haematol 2000- 111:1164−1169.
- Killick SB, Marsh JC, Gordon-Smith EC, et al.: Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia. Br J Haematol 2000- 108:582−591.
- Kim HJ, Park CY, Park YH, et al.: Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Bone Marrow Transplant 2003- 31:79−86.
- Kojima S, Hibi S, Kosaka Y, et al.: Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000- 96:2049−2054.
- Kojima S, Inaba J, Yoshimi A, et al.: Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation. Br J Haematol 2001- 114:706−711.
- Kojima S, Matsuyama K, Kodera Y, Okada J: Circulating activated suppressor T lymphocytes in hepatitis-associated aplastic anaemia. Br J Haematol 1989- 71:147−151.217
- Kojima S, Matsuyama T, Kodera Y: Hematopoietic growth factors released by marrow stromal cells from patients with aplastic anemia. Blood 1992- 79:2256−2261.
- Kojima S, Nakao S, Tomonaga M, et al.: Consensus Conference on the Treatment of Aplastic Anemia. Int J Hematol 2000- 72:118−123.
- Kojima S, Ohara A, Tsuchida M, et al.: Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 2002- 100:786−790.
- Krieger MS, Nissen C, Wodnar-Filipowicz A: Stem-cell factor in aplastic anemia: in vitro expression in bone marrow stroma and fibroblast cultures. Eur J Haematol 1995- 54:262−269.
- Laporte JR, Vidal X, Ballarin E, Ibanez L: Possible association between ocular chloramphenicol and aplastic anaemia—the absolute risk is very low. Br J Clin Pharmacol 1998- 46:181−184.
- Lazarus KH, Baehner RL: Aplastic anemia complicating infectious mononucleosis: a case report and review of the literature. Pediatrics 1981- 67:907−910.
- Lee JH, Lee JH, Shin YR, et al.: Spontaneous remission of aplastic anemia: a retrospective analysis. Haematologica 2001- 86:928−933.
- Levy RN, Sawitsky A, Florman AL, Rubin E: Fatal aplastic anemia after hepatitis. Report of five cases. N Engl J Med 1965- 273:1118−1123.
- Li FP, Alter BP, Nathan DG: The mortality of acquired aplastic anemia in children. Blood 1972−40:153−162.
- Lin CK, Gau JP, Ho CH, Wang SY: Aplastic anemia in Taiwan and its etiological factors. Taiwan Yi Xue Hui Za Zhi 1989- 88:1123−1127.
- Locasciulli A: Acquired aplastic anemia in children: incidence, prognosis and treatment options. Paediatr Drugs 2002- 4:761−766.
- Lopez-Karpovitch X, Gil-Rondero C, Hurtado-Monroy R: Long-term results of high-dose methylprednisolone in aplastic anemia. Rev Invest Clin 1991- 43:162−166.
- Lossos IS, Matzner Y: Aplastic anemia associated with amiodarone therapy. Acta Haematol 1992- 87:213.
- Lu J, Basu A, Melenhorst JJ, et al.: Analysis of T-cell repertoire in hepatitis-associated aplastic anemia. Blood 2004- 103:4588−4593.
- Lynch RE, Williams DM, Reading JC, Cartwright GE: The prognosis in aplastic anemia. Blood 1975- 45:517−528.
- Maciejewski JP OCGLTR: Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol 2007- 45:5−14.
- Maciejewski JP, Selleri C, Sato T, et al.: Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995- 91:245−252.
- Maciejewski JP, Selleri C, Sato T, et al.: A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood 1996- 88:1983−1991.
- Maciejewski JP, Sloand EM, Nunez O, et al.: Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood 2003- 102:3584−3586.
- Mackenzie IL, Manoharan A: Cyclosporine A in the treatment of aplastic anemia. Am J Hematol 1988- 28:211.
- Malkin D, Koren G, Saunders EF: Drug-induced aplastic anemia: pathogenesis and clinical aspects. Am J Pediatr Hematol Oncol 1990- 12:402−410.
- Marmont AM, Bacigalupo A, van Lint MT, et al.: Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin. Prog Clin Biol Res 1984- 148:271−287.
- Marsh JC GASM: Hematopoietic growth factors in the treatment of acquired bone marrow failure states. Semin Hematol 2007- 44:138−147.
- Marsh JC, Ball SE, Darbyshire P, et al.: Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 2003- 123:782−801.
- Marsh JC, Chang J, Testa NG, et al.: The hematopoietic defect in aplastic anemia assessed by long-term marrow culture. Blood 1990- 76:1748−1757.
- Marsh JC, Chang J, Testa NG, et al.: In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 1991- 78:258−267.
- Marsh JC, Chang J, Testa NG, et al.: Purification of aplastic anaemia (AA) marrow haemopoietic progenitors combined with long-term marrow cultures (LTMC) to assess haemopoiesis in AA. Bone Marrow Transplant 1991- 7 Suppl 2:98.
- Marsh JC, Hows JM, Bryett KA, et al.: Survival after antilymphocyte globulin therapy for aplastic anemia depends on disease severity. Blood 1987- 70:1046−1052.
- Martinez-Jaramillo G, Gomez-Morales E, Mayani H: Effect of recombinant human granulocyte macrophage-colony stimulating factor in long-term marrow cultures from patients with aplastic anemia. Am J Hematol 1999- 61:107−114.
- Mary JY, Baumelou E, Guiguet M: Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1990- 75:1646−1653.
- Mary JY, Guiguet M, Baumelou E: Drug use and aplastic anaemia: the French experience. French Cooperative Group for the Epidemiological Study of Aplastic Anaemia. Eur J Haematol Suppl 1996- 60:35−41.
- Maschan A, Bogatcheva N, Kryjanovskii O, et al.: Results at a single centre of immunosuppression with cyclosporine A in 66 children with aplastic anaemia. Br J Haematol 1999- 106:967−970.
- Mathe G AJSLCJTPSMHMSJJC: Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J 1970- 2:131−136.
- Mathe G, Schwarzenberg L: Treatment of bone marrow aplasia by bone marrow graft after conditioning with antilymphocyte globulin. Long term results. Exp Hematol 1976- 4:256−264.
- Mathe G, Schwarzenberg L: Treatment of bone marrow aplasia by mismatched bone marrow transplantation after conditioning with antilymphocyte globulin—long-term results. Transplant Proc 1976- 8:595−602.
- Mathe G, Schwarzenberg L: Selection of bone-marrow aplasia patients for allogeneic bone-marrow transplantation. Lancet 1977- 1:1361.
- Melenhorst JJ, van Krieken JH, Dreef E, et al.: T cells selectively infiltrate bone marrow areas with residual haemopoiesis of patients with acquired aplastic anaemia. Br J Haematol 1997- 99:517−519.
- Morris TC, Vincent PC: Inhibitory cells in aplastic anaemia. Br J Haematol 1982- 50:706−710.
- Myers KC, Davies SM: Hematopoietic stem cell transplantation for bone marrow failure syndromes in children. Biol Blood Marrow Transplant 2009- 15:279−292.
- Myers KC, Davies SM: Hematopoietic stem cell transplantation for bone marrow failure syndromes in children. Biol Blood Marrow Transplant 2009- 15:279−292.
- Nachbaur D, Gratwohl A, Herold M, et al.: Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia. Ann Hematol 1993- 66:71−75.
- Nagasawa T, Abe T, Hanada T: Inhibitory effects of T cells on in vitro granulopoiesis, erythropoiesis, and immunoglobulin production in patients with aplastic anaemia. Scand J Haematol 1982- 28:389−398.
- Nakao S, Takami A, Takamatsu H, et al.: Isolation of a T-cell clone showing HLA-. DRBl*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood 1997- 89:3691−3699.
- Nakao S, Yamaguchi M, Shiobara S, et al.: Interferon-gamma gene expression in unstimulated bone marrow mononuclear cells predicts a good response to cyclosporine therapy in aplastic anemia. Blood 1992- 79:2532−2535.
- Naparstek E, Amar A, Brautbar C: Suppression of mixed lymphocyte reactivity by cellular and humoral factors in aplastic anemia—both before and after bone marrow transplantation. Transplantation 1983- 36:365−369.
- Nissen-Druey C: Pathophysiology of aplastic anaemia. Blood Rev 1990- 4:97−102.
- Nistico A, Young NS: gamma-Interferon gene expression in the bone marrow of patients with aplastic anemia. Ann Intern Med 1994- 120:463−469.
- Novitzky N, Jacobs P: Marrow stem cell and stroma cell function in aplastic anaemia. Br J Haematol 1991−79:531−533.
- Novitzky N, Jacobs P: In aplastic anemia progenitor cells have a reduced sensitivity to the effects of growth factors. Eur J Haematol 1999- 63:141−148.
- Ohga S, Ichino K, Goto K, et al.: Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. Pediatr Transplant 2006- 10:497−500.
- Oriol A, Ribera JM, Hernandez A, et al.: Aplastic anemia after non-A, non-B, and non-C hepatitis. Haematologica 1994- 79:168−169.
- Osugi Y, Yagasaki H, Sako M, et al.: Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia. Haematologica 2007- 92:1687−1690.
- Ozsoylu S, Coskun T, Minassazi S: High dose intravenous glucocorticoid in the treatment of childhood acquired aplastic anaemia. Scand J Haematol 1984- 33:309−316.
- Pantel K, Boertman J, Nakeff A: Identification of the c-kit ligand: end of the road for understanding aplastic anemia in steel mutant mice? Blood 1991- 78:1428−1431.
- Paquette RL, Tebyani N, Frane M, et al.: Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood 1995- 85:283−290.
- Passweg JR, Perez WS, Eapen M, et al.: Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 2006- 37:641−649.
- Passweg JR, Socie G, Hinterberger W, et al.: Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997- 90:858−864.221
- Passweg JR, Tichelli A: Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica 2009- 94:310−312.
- Perez-Albuerne ED, Eapen M, Klein J, et al.: Outcome of unrelated donor stem cell transplantation for children with severe aplastic anemia. Br J Haematol 2008- 141:216 223.
- Perkins JL, Neglia JP, Ramsay NK, Davies SM: Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome. Bone Marrow Transplant 2001- 28:523−526.
- Pisciotta AV: Drug-induced leukopenia and aplastic anemia. Clin Pharmacol Ther 1971- 12:13−43.
- Raefsky EL, Gascon P, Gratwohl A, et al.: Biological and immunological characterization of ATG and ALG. Blood 1986- 68:712−719.
- Reiter E, Keil F, Brugger S, et al.: Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia. Bone Marrow Transplant 1997- 19:1191−1196.
- RHEINGOLD JJ, SPURLING CL: Chloramphenicol and aplastic anemia. J Am Med Assoc 1952- 119:1301−1304.
- Rizzo S, Scopes J, Elebute MO, et al.: Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow. Hematol J 2002- 3:230−236.
- Rogentine GN, Jr., Rosenberg EB, Merritt CB, et al.: Antilymphocyte globulin as the sole immunosuppressant for bone marrow transplantation in aplastic anemia. A case report. Transplantation 1973- 15:514−517.
- Rosenberg AH: Methimazol induced aplastic anemia. Conn Med 1970- 34:32−35.
- Rosenfeld S, Follmann D, Nunez O, Young NS: Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003- 289:1130−1135.
- Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995- 85:3058−3065.
- Safadi R, Or R, Ilan Y, et al.: Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation. Bone Marrow Transplant 2001- 27:183−190.
- Saitoh T, Matsushima T, Yamane A, et al.: Hodgkin lymphoma accompanied by aplastic anemia and polyclonal expansion of large granular lymphocytes. Acta Haematol 2007- 117:238−241.
- Sanchez-Medal L, Gomez-Leal A, Duarte L, Guadalupe RM: Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood 1969- 34:283−300.231 232 233 234 235,236,237,238.239.240,241,242,243.244,245,
- Scheinberg P, Nunez O, Wu C, Young NS: Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. Br J Haematol 2006- 133:606−611.
- Scheinberg P, Wu CO, Nunez O, Young NS: Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 2009- 144:206−216.
- Schrezenmeier H. BA: «Aplastic anemia: pathophysiology and treatment. «2000.
- Schrezenmeier H, Marin P, Raghavachar A, et al.: Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 1993- 85:371−377.
- Schrezenmeier H, Noe G, Raghavachar A, et al.: Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia. Br J Haematol 1994- 88:286−294.
- Schultz JC, Shahidi NT: Detection of tumor necrosis factor-alpha in bone marrow plasma and peripheral blood plasma from patients with aplastic anemia. Am J Hematol 1994- 45:32−38.
- Seip M, Vidnes J: Cyclosporine A in a case of refractory severe aplastic anaemia. Scand J Haematol 1985- 34:228−230.
- Semikina EL, Torubarova NA, Zharov VN: Membrane markers and interleukin-2 receptor of splenic lymphocytes in children with aplastic anemia: detection of active subpopulations. Gematol Transfuziol 1990- 35:24−26.
- Shahidi NT, Diamond LK: Testosterone-induced remission in aplastic anemia. AMA J Dis Child 1959- 98:293−302.
- Shahidi NT, Diamond LK: Testosterone-induced remission in aplastic anemia of both acquired and congenital types. Further observations in 24 cases. N Engl J Med 1961- 264:953−967.
- Shapiro S, Issaragrisil S, Kaufman DW, et al.: Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 1999- 60:573−577.
- Silingardi V, Torelli U: Recovery from aplastic anemia after treatment with antilymphocyte globulin. Arch Intern Med 1979- 139:582−583.
- Silingardi V, Venezia L, Federico M, et al.: Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin (author's transl). Haematologica 1979- 64:66−76.
- Smick KM, Condit PK, Proctor RL, Sutcher V: Fatal aplastic anemia an. Epidepidemiological Study of its relationship to the drug Chloramfenicol. J Chronic Dis 1964- 17:899−914.
- Speck B, Gluckman E, Haak HL, van Rood JJ: Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet 1977−2:1145−1148.
- Speck B, Gluckman E, Haak HL, van Rood JJ: Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion. Clin Haematol 1978- 7:611 621.
- Speck B, Gratwohl A, Nissen C, et al.: Bone marrow graft versus ALG in patients with aplastic anaemia. Biomed Pharmacother 1983- 37:139−143.
- Speck B, Gratwohl A, Nissen C, et al.: A comparison between ALG and bone marrow transplantation in treatment of severe aplastic anemia. Thymus 1987- 10:147−158.
- Speck B, Kissling M: Successful bone marrow grafts in experimental aplastic anemia using antilymphocytic serum for conditioning. Rev Eur Etud Clin Biol 1971- 16:10 471 051.
- Speck B, Kissling M: Studies on bone marrow transplantation in experimental 32P-induced aplastic anemia after conditioning with antilymphocyte serum. Acta Haematol 1973−50:193−199.
- Speck B, Nissen C, Tichelli A, Gratwohl A: Treatment of Aplastic Anemia. Oncologist 1996- 1:367−370.
- Speck B, Tichelli A, Widmer E, et al.: Splenectomy as an adjuvant measure in the treatment of severe aplastic anaemia. Br J Haematol 1996- 92:818−824.
- Storb R: Bone marrow transplantation for aplastic anemia. Cell Transplant 1993- 2:365 379.
- Storb R, Etzioni R, Anasetti C, et al.: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994- 84:941−949.
- Storb R, Leisenring W, Anasetti C, et al.: Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin. Blood 1997- 89:3890−3891.
- Storb R, Longton G, Anasetti C, et al.: Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant 1992- 10 Suppl 1:45−52.
- Storb R, Prentice RL, Thomas ED, et al.: Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol 1983- 55:573 585.
- Storb R, Thomas ED, Buckner CD, et al.: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 1974- 43:157−180.
- Storb R, Thomas ED, Weiden PL, et al.: Aplastic anemia treated by allogeneic bone marrow transplantation: a report on 49 new cases from Seattle. Blood 1976- 48:817−841.
- Stryckmans PA, Dumont JP, Velu T, Debusscher L: Cyclosporine in refractory severe aplastic anemia. N Engl J Med 1984- 310:655−656.
- Sturgeon P: Fatal aplastic anemia in children following chloramphenicol (Chloromycetin) therapy- report of four cases. J Am Med Assoc 1952- 149:918−922.
- Szklo M. LMSMLDeal: Incidence of aplastic anemia in a three country area in South Carolina. Cancer Res 1986- 46:426−429.
- Szklo M, Sensenbrenner L, Markowitz J, et al.: Incidence of aplastic anemia in metropolitan Baltimore: a population-based study. Blood 1985- 66:115−119.
- Taher A, Ammash Z, Dabajah B, et al.: Ticlopidine-induced aplastic anemia and quick • recovery with G-CSF: case report and literature review. Am J Hematol 2000- 63:90−93.
- Takahashi T, Sugiyama H, Yagita M, et al.: Suppressive lymphocytes against CFU-C in relation to therapeutic response to glucocorticoid in patients with aplastic anemia. Nippon Ketsueki GakkaiZasshi 1985- 48:910−920.
- Takai K, Fujiwara M, Takahashi M, et al.: Studies on human T cell colonies (2). T cell colony formation in patients with aplastic anemia and the effects of steroid hormones on T cell colony formation. Rinsho Ketsueki 1982- 23:1069−1076.
- Te VJ, Haak HL: Aplastic anaemia. Histological investigation of methacrylate embedded bone marrow biopsy specimens- correlation with survival after conventional treatment in 15 adult patients. Br J Haematol 1977- 35:61−69.
- Teramura M, Kobayashi S, Iwabe K, et al.: Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br J Haematol 1997- 96:80−84.
- Thollot F, Bordigoni P, Olive D: Paroxysmal nocturnal hemoglobinuria and aplastic anemia. Arch Fr Pediatr 1984- 41:197−200.
- Thomas ED, Storb R, Fefer A, et al.: Aplastic anaemia treated by marrow transplantation. Lancet 1972- 1:284−289.
- Thomas ED, Storb R, Giblett ER, et al.: Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol 1976- 4:97−102.
- Tichelli ASHaBA: Immunosupressive treatment of aplastic anemia. In «Aplastic Anemia: pathophysiology and treatment.» United Kingdom, Cambrige Univercity Press., 1999.
- Tisdale JF, Dunn DE, Geller N, et al.: High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial. Lancet 2000- 356:1554−1559.
- Tisdale JF, Dunn DE, Maciejewski J: Cyclophosphamide and other new agents for the treatment of severe aplastic anemia. Semin Hematol 2000- 37:102−109.
- Tisdale JF, Maciejewski JP, Nunez O, et al.: Late complications following treatment for severe aplastic anemia (SAA) with high-dose cyclophosphamide (Cy): follow-up of a randomized trial. Blood 2002- 100:4668−4670.
- Torres HA, Bodey GP, Roiston KV, et al.: Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 2003- 98:86−93.
- Trede NS, Warwick AB, Rosoff PM, et al.: Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Bone Marrow Transplant 1997- 20:257−260.
- Trivier JM, Caron J, Mahieu M, et al.: Fatal aplastic anaemia associated with Clopidogrel. Lancet 2001- 357:446.
- Umeda K, Adachi S, Watanabe K, et al.: Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation. Bone Marrow Transplant 2002- 30:531−534.
- Unal S, Cetin M, Tavil B, et al.: Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients. Pediatr Transplant 2007- 11:788−791.
- Viollier R, Passweg J, Gregor M, et al.: Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Ann Hematol 2005- 84:47−55.
- Viollier R, Socie G, Tichelli A, et al.: Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008- 41:45−50.
- Wen JQ, Feng HL, Wang XQ, Pang JP: Hemogram and bone marrow morphology in children with chronic aplastic anemia and myelodysplastic syndrome. World J Pediatr 2008- 4:36−40.
- Wiholm BE, Kelly JP,' Kaufman D, et al.: Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ 1998- 316:666.
- Williams DM, Lynch RE, Cartwright GE: Drug-induced aplastic anemia. Semin Hematol 1973- 10:195−223.
- Wisloff F, Godal HC: Cyclosporine in refractory severe aplastic anemia. N Engl J Med 1985−312:1193.
- Wodnar-Filipowicz A, Chklovskaia E, Manz CY, et al.: Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia. Exp Hematol 1997- 25:573−581.
- Yagasaki H, Takahashi Y, Kudo K, et al.: Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia. Int J Hematol 2007- 85:437−442.
- Yetgin S, Ozyurek E, Asian D, Cetin M: Metamizole sodium-induced severe aplastic anemia and its recovery with a short-course steroid therapy. Pediatr Hematol Oncol 2004- 21:343−347.
- Young N. and Mortimer P.: Viruses and bone marrow failure. Blood 1984- 63:729−737.
- Young NS: Acquired aplastic anemia. Ann Intern Med 2002- 136:534−546.
- Young NS, Barrett AJ: The treatment of severe acquired aplastic anemia. Blood 1995- 85:3367−3377.
- Young NS, Issaragrasil S, Chieh CW, Takaku F: Aplastic anaemia in the Orient. Br J Haematol 1986- 62:1−6.
- Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 1997- 336:1365−1372.
- Young NS, Maciejewski J: The pathophysiology of acquired aplastic anemia. N Engl J Med 1997- 336:1365−1372.
- Young NS, Scheinberg P, Calado RT: Aplastic anemia. Curr Opin Hematol 2008- 15:162−168.
- Zeldis JB, Dienstag JL, Gale RP: Aplastic anemia and non-A, non-B hepatitis. Am J Med 1983- 74:64−68.I